Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 27, 2022

Twi Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for TWI PHARMS, and what generic and branded alternatives to TWI PHARMS drugs are available?

TWI PHARMS has eighteen approved drugs.

Summary for Twi Pharms

US Patents:	0
Tradenames:	17
Ingredients:	17
NDAs:	18

Drugs and US Patents for Twi Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Twi Pharms	GUANFACINE HYDROCHLORIDE	guanfacine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	201408-003	Jun 2, 2015	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Twi Pharms	FLUPHENAZINE HYDROCHLORIDE	fluphenazine hydrochloride	TABLET;ORAL	215848-003	Apr 1, 2022	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Twi Pharms	GUANFACINE HYDROCHLORIDE	guanfacine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	201408-004	Jun 2, 2015	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Twi Pharms	DONEPEZIL HYDROCHLORIDE	donepezil hydrochloride	TABLET;ORAL	203104-001	Oct 29, 2014	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Twi Pharms	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	210081-002	Nov 3, 2017	AB3	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon

AstraZeneca

Boehringer Ingelheim

Mallinckrodt

Medtronic

McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.